Contribution of interleukin 1β and KM loci to alopecia areata

Human Heredity

Volumn 49, Issue 2, 1999, Pages 85-89

  Galbraith, Gillian M P ^a   Palesch, Yuko ^b   Gore, Elizabeth A ^a   Pandey, Janardan P ^a  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Alopecia areata; IL 1 polymorphisms; KM

Indexed keywords

IMMUNOGLOBULIN KAPPA CHAIN; INTERLEUKIN 1BETA; INTERLEUKIN 1;

ALOPECIA AREATA; ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN GENE; MAJOR CLINICAL STUDY; NUCLEIC ACID BASE SUBSTITUTION; ADOLESCENT; ADULT; CHILD; CHROMOSOME 2; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETICS; HETEROZYGOTE; HOMOZYGOTE;

ADOLESCENT; ADULT; ALOPECIA AREATA; CHILD; CHROMOSOMES, HUMAN, PAIR 2; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMANS; IMMUNOGLOBULIN KAPPA-CHAINS; INTERLEUKIN-1; POLYMORPHISM, GENETIC;

EID: 0032588025     PISSN: 00015652     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022850     Document Type: Article

References (30)

1. Thiers BH, Galbraith GMP: The pathogenesis of alopecia areata; in Thiers BH, Dobson RL (eds): Pathogenesis of Skin Disease. New York, Churchill-Livingstone, 1985, pp 57-64.
2. van der Steen P, Traupe H, Happle R, Boezeman J, Strater R, Hamm H: The genetic risk for alopecia areata in first degree relatives of severely affected patients. Acta Derm Venereol (Stockh) 1992;72:373-375.
3. Ødum N, Morling N, Georgsen J, Frentz BK, Jensen GF, Fugger L, Svejgaard A: HLA-DP antigens in patients with alopecia areata. Tissue Antigens 1990;35:114-117.
4. Duvic M, Hordinsky MK, Fiedler VC, O'Brien WR, Young R, Reveilly JD: HLA-D locus associations in alopecia areata. Arch Dermatol 1991;127:64-68.
5. Morling N, Frentz G, Fugger L, Georgsen J, Jakobsen B, Ødum N, Svejgaard A: DNA polymorphism of HLA class II genes in alopecia areata. Dis Markers 1991;9:35-42.
6. Colombe BW, Price VH, Khoury EL, Garovoy MR, Lou CD: HLA class II antigen associations help to define two types of alopecia areata. J Am Acad Dermatol 1995;33:757-764.
7. Galbraith GMP, Thiers BH, Pandey JP: Gm allotype-associated resistance and susceptibility to alopecia areata. Clin Exp Immunol 1984; 56:149-152.
8. Galbraith GMP, Pandey JP: KM1 allotype association with one subgroup of alopecia areata. Am J Hum Genet 1989;44:426-428.
9. Galbraith GMP, Pandey JP: Tumor necrosis factor alpha (TNF-α) gene polymorphism in alopecia areata. Hum Genet 1995;96:433-436.
10. Tarlow JK, Clay FE, Cork MJ, Blakemore AIF, McDonagh AJG, Messenger AG, Duff GW: Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol 1994;103: 387-390.
11. Wilson AG, di Giovine FS, Duff GW: Genetics of tumour necrosis factor-α in autoimmune, infectious, and neoplastic diseases. J Inflamm 1995;45:1-12.
12. Cox A, Camp NJ, Nicklin MJH, di Giovane FS, Duff GW: An analysis of linkage disequilibrium in the interleukin-1 gene cluster, using a novel grouping method for multiallellic markers. Am J Hum Genet 1998;62:1180-1188.
13. Kornman KS, Crane A, Wang H-Y, di Giovane FS, Newman MG, Pirk FW, Wilson TG Jr, Higginbottom FL, Duff GW: The interleukin-1 genotype as a severity factor in adult periodontal disease. J Clin Periodontol 1997;24:72-77.
14. Pociot F, Mølvig J, Wogensen L, Worsaae H, Nerup J: Taql polymorphism in the human interleukin-1β (IL-1β) gene correlates with IL-1β secretion in vitro. Eur J Clin Invest 1992;22: 396-402.
15. Hoffmann R, Happle R: Does interleukin-1 induce hair loss? Dermatology 1995;191:273-275.
16. Philpott MP, Sanders DA, Bowen J, Kealey T: Effects of interleukins, colony-stimulating factor and tumour necrosis factor on human hair follicle growth in vitro: A possible role for interleukin-1 and tumour necrosis factor-a in alopecia areata. Br J Dermatol 1996; 135:942-948.
17. Hoffmann R, Eicheler W, Wenzel E, Happle R: Interleukin-1β-induced inhibition of hair growth in vitro is mediated by cyclic AMP. J Invest Dermatol 1997;108:40-42.
18. Hoffmann R, Wenzel E, Huth A, van der Steen P, Schäufele M, Henninger H-P: Cytokine mRNA levels in alopecia areata before and after treatment with the contact allergen diphenylcyclopropenone. J Invest Dermatol 1994; 103:530-533.
19. +3953 allele 2: Association with disease status in adult periodontitis. J Clin Periodontol 1998;25:781-785.
20. Moxley G. Gibbs RS: Polymerase chain reaction-based genotyping for allotypic markers of immunoglobulin kappa shows allelic association of KM with kappa variable segments. Genomics 1992;13:104-108.
21. SAS Institute: SAS/STAT User's Guide, version 6, ed 4. Cary, SAS Institute, 1990, vol 1, 2.
22. Kroeger KR, Abraham LJ: Identification of an AP-2 element in the -323 to -285 region of the TNF-alpha gene. Biochem Mol Biol Int 1996; 40:43-51.
23. Wilson AG, Symons JA, McDowell TL, McDevitt HO, Duff GW: Effects of a polymorphism in the human tumor necrosis factor alpha promoter on transcriptional activation. Proc Natl Acad Sci USA 1997;94:3195-3199.
24. Brinkman BMN, Zujidgeest D, Kaijzel EL, Breedveld FC, Verweij CL: Relevance of the tumor necrosis factor alpha (TNF-alpha)-308 promoter polymorphism in TNF-alpha gene regulation. J Inflammation 1996;46:32-41.
25. Stuber F, Udalova IA, Book M, Drutskaya LN, Kuprash DV, Turetskaya RL, Schade FU, Nedospasov: -308 tumor necrosis factor (TNF) polymorphism is not associated with survival in severe sepsis and is unrelated to lipopolysaccharide inducibility of the human TNF promoter. J Inflammation 1996;46:42-50.
26. McGuire W, Hill AVS, Allsop CEM, Greenwood BM, Kwiatkowski D: Variation in the TNF-α promoter region associated with susceptibility to cerebral malaria. Nature 1994; 371:508-511.
27. Nadel S, Newport MJ, Booy R, Levin M: Variation in the tumor necrosis factor-alpha gene promoter region may be associated with death from meningococcal disease. J Infect Dis 1996; 174:878-880.
28. Santtila S, Savinainen K, Hurme M: Presence of the IL-1RA allele 2 (IL1RN*2) is associated with enhanced IL-1-beta production in vitro. Scand J Immunol 1998;47:195-198.
29. Whittingham S, Mathews JD, Schanfield MS, Tait BD, Mackay IR: Interaction of HLA and Gm in autoimmune chronic active hepatitis. Clin Exp Immunol 1981;43:80-86.
30. Whittingham S, Mathews JD, Schanfield MS, Tait BD, Mackay IR: HLA and Gm genes in systemic lupus erythematosus. Tissue Antigens 1983;21:50-57.